Amy Jacob

Francisco Sylvester, MD, UNC School of medicine emphasized the importance of applying study findings to early interventions in treatment.

Francisco A. Sylvester, MD, UNC School of Medicine talked about the different ways in which the care of pediatric IBD differs from adult IBD.

Peter Higgins, MD, PhD, University of Michigan Health System, talked about how patients these days are often answering their own nutritional questions on the "Wild Wild West" of the Internet, so it's up to the experts to provide thorough answers to assuage their concerns.

At the 2015 Advances in Inflammatory Bowel Diseases (AIBD) meeting in Orlando, Florida, Peter Higgins, MD, PhD, the University of Michigan Health System shared his insight about the importance and value of careful nutritional guidance for IBD patients.

Eva Szigethy, MD, PhD, University of Pittsburgh discussed at the 2015 Advances in Inflammatory Bowel Diseases (AIBD) how to continue the conversation and implement methods to treat the burgeoning concern of opioid dependence among pediatric IBD patients.

Miguel Regueiro, MD, University of Pittsburgh Medical Center, highlighted the hot topics in IBD at the 2015 Advances in Inflammatory Bowel Diseases.

Russell Cohen, MD, director of the Inflammatory Bowel Diseases Center at The University of Chicago Medicine continued to discuss the relevance of healthcare economics specific to IBD at the 2015 Advances in Inflammatory Bowel Diseases.

Russell Cohen, MD, director of the Inflammatory Bowel Diseases Center at The University of Chicago Medicine, discussed the progress made not only in the clinical care of IBD, but also in the basic science group and translational core at the 2015 Advances in Inflammatory Bowel Diseases meeting in Orlando, FL.

Barbara Cappelli, MD, Eurocord International Registry, Paris, France, shared an overview from her team's study that found further evidence that for patients with severe sickle cell disease who have an HLA-identical sibling available as a donor, HSCT can be safe and effective.

Mitchell Smith, MD, Cleveland Clinic shared highlights of his team's posters and discussed the progression of immunotherapies at the 57th American Society of Hematology Annual Meeting.

Brian Bolwell, MD, Cleveland Clinic, discussed how all the information they're finding out about myeloid malignancies is very important, but also complex so making broad statements is challenging.

At the 57th American Society of Hematology Annual Meeting, Christine Cserti-Gazdewich, BSc, MD, Blood Transfusion Laboratory, Toronto General Hospital discussed the progress made in blood unit storage.

Christine Cserti-Gazdewich, BSc, MD, Blood Transfusion Laboratory, Toronto General Hospital, and colleagues wanted to address the burgeoning concern that the longer blood units are stored, the likelier it may be to introduce harm or simply not work as well.

Seth Karol, MD, St. Jude's Children's Research Center and his team focused their research on the 10-20 age group, the "sweet spot" where the bones are still finishing up development and thus going to be susceptible to therapy.

Seth Karol, MD, St. Jude's Children's Research Center discussed several ways in which he and his colleagues intensified therapy over the years and referred to a key toxicity that had emerged from the two drugs they used.

Researchers assessed the effect of epoetin alfa biosimilar both with and without iron supplementation on CIA in patients undergoing treatment for oncologic and hematologic malignancies.

Sickle cell disease, as debilitating as it is, is associated with the progressive complication of renal damage – beginning with hyerfiltration in childhood to glomerular filtration rate (GFR) decline and chronic renal failure in approximately 12 % of HbSS sickle cell adults.

Patients suffering from the most common hereditary bleeding disorder von Willebrand disease (VWD) also undergoing surgical procedures are recommended specific treatment methods to manage perioperative anticoagulation.

It has become unnecessary for dermatologists to request monthly lab tests for patients administered standard doses of isotretinoin for the treatment of severe acne.

Adding potatoes, despite their high carbohydrate content, to one's daily diet can reduce the likelihood of stomach cancer by one third.

The key to determining the level to which inflammatory bowel disease (IBD) patients might become sick is to understand patients' genetic variation.

Acne patients with darker skin tones found relief with chemical peels using 25% trichloroacetic acid (TCA) and 30% salicylic acid.

Increasing daily intake of walnuts has been linked to lower cholesterol levels, overall weight, and quality of diet.

The risk of developing psoriasis can be attributed to infections, not antibiotic use.

Interleukin 1 receptor antagonist Anakinra was found to benefit patients afflicted with severe hidradenitis suppurativa, a common skin disorder characterized by excessive inflammation.

The severity of nail and scalp psoriasis was significantly reduced in patients who received twice-daily treatment with Otezla (apremilast, Celgene).

Always a brewing topic, coffee drinking has been linked to a lower risk of dying from heart disease.

College kids who break out or get hives can, in fact, blame some of their skin problems on heightened levels of psychological stress.

Mobile applications can significantly aid in treatment for gastrointestinal conditions.

Recent research has discovered evidence potentially supporting a parent-of-origin effect in psoriatic disease.